In contrast, TFEB-mediated lysosome biogenesis has been verified only for paeonol and morroniside, while SIRT3-dependent lipophagy is presently limited to berberine in diabetic cardiomyopathy and warrants confirmation in DKD models. The gene discussed is TFEB; the disease is diabetic kidney disease.